Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin for Sleep Disorders in Hepatic Encephalopathy
NCT02163837Completed
- Sponsor
- Saint-Pierre University Hospital
- Start
- Mar 2014
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of rifaximin in hepatic encephalopathy (HE), sponsored by Saint-Pierre University Hospital. Primary endpoint: Percentage of Slow Wave Sleep and REM Sleep at 28 days. Started Mar 2014; status: completed.
02
Drugs
rifaximin
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT02163837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02163837.